FRE Stock Overview
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Fresenius SE & Co. KGaA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €26.90 |
| 52 Week High | €31.22 |
| 52 Week Low | €23.93 |
| Beta | 1.08 |
| 1 Month Change | 7.99% |
| 3 Month Change | 2.36% |
| 1 Year Change | 4.51% |
| 3 Year Change | -32.31% |
| 5 Year Change | -47.07% |
| Change since IPO | 2,282.65% |
Recent News & Updates
Does Fresenius SE KGaA (ETR:FRE) Have A Healthy Balance Sheet?
Mar 29
Fresenius SE KGaA (ETR:FRE) Could Be At Risk Of Shrinking As A Company
Mar 13Why Fresenius SE & Co. KGaA (ETR:FRE) Could Be Worth Watching
Feb 06Recent updates
Does Fresenius SE KGaA (ETR:FRE) Have A Healthy Balance Sheet?
Mar 29Fresenius SE KGaA (ETR:FRE) Could Be At Risk Of Shrinking As A Company
Mar 13Why Fresenius SE & Co. KGaA (ETR:FRE) Could Be Worth Watching
Feb 06A Look At The Fair Value Of Fresenius SE & Co. KGaA (ETR:FRE)
Jan 19Fresenius SE & Co. KGaA's (ETR:FRE) Shares Not Telling The Full Story
Jan 03Does Fresenius SE KGaA (ETR:FRE) Have A Healthy Balance Sheet?
Nov 28Fresenius SE & Co. KGaA (ETR:FRE) Analysts Just Trimmed Their Revenue Forecasts By 34%
Nov 10Fresenius SE KGaA (ETR:FRE) Is Reinvesting At Lower Rates Of Return
Oct 27Is It Too Late To Consider Buying Fresenius SE & Co. KGaA (ETR:FRE)?
Sep 03Some Investors May Be Worried About Fresenius SE KGaA's (ETR:FRE) Returns On Capital
Jul 25We Think Fresenius SE KGaA (ETR:FRE) Is Taking Some Risk With Its Debt
Jun 19At €25.59, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?
Jun 01Capital Allocation Trends At Fresenius SE KGaA (ETR:FRE) Aren't Ideal
Apr 18Fresenius SE KGaA's (ETR:FRE) Soft Earnings Are Actually Better Than They Appear
Mar 13These 4 Measures Indicate That Fresenius SE KGaA (ETR:FRE) Is Using Debt Extensively
Mar 10Are Investors Undervaluing Fresenius SE & Co. KGaA (ETR:FRE) By 38%?
Feb 23Is It Too Late To Consider Buying Fresenius SE & Co. KGaA (ETR:FRE)?
Feb 08The Returns On Capital At Fresenius SE KGaA (ETR:FRE) Don't Inspire Confidence
Jan 03These 4 Measures Indicate That Fresenius SE KGaA (ETR:FRE) Is Using Debt Extensively
Nov 28Should You Investigate Fresenius SE & Co. KGaA (ETR:FRE) At €21.71?
Oct 23The Returns On Capital At Fresenius SE KGaA (ETR:FRE) Don't Inspire Confidence
Oct 01Is Fresenius SE KGaA (ETR:FRE) Using Too Much Debt?
Aug 07Is It Time To Consider Buying Fresenius SE & Co. KGaA (ETR:FRE)?
Jul 20Fresenius SE KGaA (ETR:FRE) May Have Issues Allocating Its Capital
Jul 02Fresenius SE KGaA (ETR:FRE) Is Increasing Its Dividend To €0.92
Apr 28At €34.09, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?
Apr 17Fresenius SE KGaA (ETR:FRE) Is Paying Out A Larger Dividend Than Last Year
Apr 02Fresenius SE KGaA (ETR:FRE) Could Be Struggling To Allocate Capital
Mar 27Fresenius SE KGaA's (ETR:FRE) Upcoming Dividend Will Be Larger Than Last Year's
Feb 24Is Now An Opportune Moment To Examine Fresenius SE & Co. KGaA (ETR:FRE)?
Jan 13Here's Why Fresenius SE KGaA (ETR:FRE) Has A Meaningful Debt Burden
Dec 29Fresenius SE KGaA (ETR:FRE) Could Be Struggling To Allocate Capital
Dec 14At €41.20, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?
Oct 15Is Fresenius SE KGaA (ETR:FRE) A Risky Investment?
Sep 30Fresenius SE KGaA (ETR:FRE) Is Reinvesting At Lower Rates Of Return
Sep 15Is Now The Time To Look At Buying Fresenius SE & Co. KGaA (ETR:FRE)?
Jul 17Fresenius SE KGaA (ETR:FRE) Takes On Some Risk With Its Use Of Debt
Jul 01There Are Reasons To Feel Uneasy About Fresenius SE KGaA's (ETR:FRE) Returns On Capital
Jun 14Should Shareholders Reconsider Fresenius SE & Co. KGaA's (ETR:FRE) CEO Compensation Package?
May 15Should You Think About Buying Fresenius SE & Co. KGaA (ETR:FRE) Now?
Apr 06Shareholder Returns
| FRE | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 5.8% | 4.1% | -1.5% |
| 1Y | 4.5% | -0.8% | 0.9% |
Return vs Industry: FRE exceeded the German Healthcare industry which returned -0.8% over the past year.
Return vs Market: FRE exceeded the German Market which returned 0.9% over the past year.
Price Volatility
| FRE volatility | |
|---|---|
| FRE Average Weekly Movement | 3.3% |
| Healthcare Industry Average Movement | 5.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: FRE has not had significant price volatility in the past 3 months.
Volatility Over Time: FRE's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1912 | 193,865 | Michael Sen | www.fresenius.com |
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.
Fresenius SE & Co. KGaA Fundamentals Summary
| FRE fundamental statistics | |
|---|---|
| Market cap | €15.15b |
| Earnings (TTM) | €353.00m |
| Revenue (TTM) | €22.30b |
42.9x
P/E Ratio0.7x
P/S RatioIs FRE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FRE income statement (TTM) | |
|---|---|
| Revenue | €22.30b |
| Cost of Revenue | €17.24b |
| Gross Profit | €5.06b |
| Other Expenses | €4.71b |
| Earnings | €353.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 08, 2024
| Earnings per share (EPS) | 0.63 |
| Gross Margin | 22.68% |
| Net Profit Margin | 1.58% |
| Debt/Equity Ratio | 70.4% |
How did FRE perform over the long term?
See historical performance and comparison